Abstract
Angiopoietin-1 (Ang1) binds to and activates Tie2 receptor tyrosine kinase. Ang1-Tie2 signal has been proposed to exhibit two opposite roles in the controlling blood vessels. One is vascular stabilization and the other is vascular angiogenesis. There has been no answer to the question as to how Tie2 induces two opposite responses to the same ligand. Our group and Dr. Alitalo's group have demonstrated that trans-associated Tie2 at cell-cell contacts and extracellular matrix (ECM)-anchored Tie2 play distinct roles in the endothelial cells. The complex formation depends on the presence or absence of cell-cell adhesion. Here, we review how Ang1-Tie2 signal regulates vascular maintenance and angiogenesis. We further point to the unanswered questions that must be clarified to extend our knowledge of vascular biology and to progress basic knowledge to the treatment of the diseases in which Ang1-Tie2-mediated signal is central.
Similar content being viewed by others
Introduction
Blood vessels are developed in embryogenesis and reorganized in ischemia and cancer to deliver oxygen and nutrients to the tissues. Vascular formation during embryogenesis requires both vasculogenesis and angiogenesis, whereas neovascular formation in adult requires angiogenesis (Adams and Alitalo, 2007). Therefore, in the adult vasculature, blood vessels are maintained by the balance between vascular stabilization and vascular angiogenesis. Vascular stabilization depends on the coordination of cell-cell adhesion and cell survival. Vascular angiogenesis depends on the de-adhesion of pre-existing cell-cell adhesion and migration/proliferation of endothelial cells.
The inter-endothelial cell adhesion and the adhesion between endothelial cells and mural cells are regulated by cell-cell adhesion molecules, and thereby contribute to cell survival. Vascular endothelial cadherin (VE-cadherin) and N-cadherin elicit adhesive functions in inter-endothelial cell junctions and endothelial-mural cell junctions, respectively. In addition to the adhesion molecules, endothelial cell-specific growth factors and their receptor-mediated signals play central roles in endothelial cell survival. Receptor tyrosine kinases including vascular endothelial growth factor receptor (VEGF-R), Eph, and Tie family are required for vascular formation (Adams and Alitalo, 2007).
Among endothelial cell-specific receptors, Tie2 receptor-mediated signaling exhibits a vascular protective action. Tie2 constitutes the Tie family and dimerizes with Tie1 and functions as a receptor for angiopoietin-1 (Ang1) (Saharinen et al., 2005). The Ang family consists of Ang1, Ang2, Ang3, and Ang4 (Valenzuela Koh et al., 1999; Koh et al., 2002; Lee et al., 2004). Of them, Ang1 and Ang2 are well characterized (Gale et al., 2002; Fiedler et al., 2006a; Fiedler and Augustin, 2006). Ang1 binds to and activates Tie2, while Ang2 has similar affinity to Tie2 to compete with the binding of Ang1 to Tie2. Therefore, Ang2 is thought to inhibit Ang1-mediated vascular protective action. It is also reported that Ang1-Tie2 is essential for developmental angiogenesis, ischemia-induced angiogenesis, and tumor angiogenesis. Hence, the Ang1-Tie2 signal plays central roles in two opposing vascular regulation: vascular quiescence and angiogenesis (Figure 1). However, it is not known how Ang1-Tie2 signal regulates two paradoxical actions. Here, we focus on Ang1-Tie2 signaling and do not refer to the details of other Ang family and Tie1. Ang and Tie are elegantly reviewed elsewhere (Brindle et al., 2006; Fiedler and Augustin, 2006). We and Alitalo's group have recently demonstrated the different signals mediated by Tie2 in the presence or absence of endothelial cell-cell contacts (Fukuhara et al., 2008; Saharinen et al., 2008). One is trans-associated Tie2 by Ang1 and the other is extracellular matrix-anchored Tie2 by Ang1. In this review, we further suggest that these distinct signals may play specific roles in vascular quiescence and angiogensis.
Ang1-mediated vascular stabilization
Ang1 induces endothelial cell survival, inhibits vascular leakage, and reduces vascular inflammation. All these effects of Ang1 on vascular endothelial cells lead to preservation of vasculature from vascular damage. Ang1 activates phosphatidylinositol 3-kinase and subsequently induces phosphorylation of AKT, which plays essential roles in cell survival (Kim et al., 2000; Papapetropoulos et al., 2000). Pro-apoptotic activities of the AKT substrates are inhibited by the phosphorylation by AKT, resulting in cell survival (Manning and Cantley, 2007; Duronio, 2008). Ang1 reduces vascular leakage by strengthening PECAM-1 and VE-cadherin-regulated inter-endothelial adhesion (Gamble et al., 2000). In vivo, Ang1 antagonizes VEGF-induced vascular permeability (Thurston et al., 2000). Moreover, Ang1 protects endothelial cells from VEGF-induced inflammation by inhibiting the expression of ICAM-1 and VCAM-1 on endothelial cells, which are required for the attachment of inflammatory cell infiltration into the vasculature (Kim et al., 2001b). Accumulating evidence indicate that the inter-endothelial cell-cell adhesion and Ang1-Tie2 signaling co-operatively regulate endothelial cell survival and vascular integrity to maintain the established vasculature. Ang1 is produced from mural cells that support the endothelial cells. Thus, both inter-endothelial cell adhesions and endothelial-mural cell adhesions are important for maintenance of vascular integrity. By contrast, it is of note that Ang2 produced in endothelial cells and stored in Weibel-Palade bodies are released to induce inflammation, resulting in destabilization of endothelial cell adhesion (Fiedler et al., 2004, 2006b; Scharpfenecker et al., 2005). Thus, stabilization and destabilization may be balanced by the counteraction on Ang1 and Ang2.
Ang1-Tie2 in angiogenesis
In clear contrast, during angiogenesis cell-cell adhesions must be disassembled to accelerate the branching and sprouting of new vessels. Therefore, the vascular reorganization process must overcome stabilization. Ang1-Tie2 signal is required for developmental angiogenesis during embryogenesis (Dumont et al., 1994; Sato et al., 1995; Suri et al., 1996). In adult vascular angiogenesis, the activation of Tie2 has been reported in tumor vessels and remodeling vessels, suggesting the involvement of Ang1-Tie2 signal in adult angiogenesis (Wong et al., 1997; Peters et al., 2004).
Angiogenesis requires vascular endothelial cell proliferation and migration. Although the proliferation of vascular endothelial cells has been controversial (Witzenbichler et al., 1998; Kanda et al., 2005), ERK activation, the hallmark of proliferation, by Ang1 has been reported (Kim et al., 2002; Harfouche et al., 2003). It is still unclear how Ang1-Tie2 signal induces ERK activation. Tie2-mediated endothelial cell migration involves Dok-R. Dok-R is an adaptor molecule, which contains multi-phosphotyrosines and signals multiple downstream molecules including Nck (Master et al., 2001; Jones et al., 2003). Cell migration is also controlled by Rho family GTPases, Rac and Rho. The activation of Rac1 by Ang1 is suggested to be involved in endothelial cell migration (Cascone et al., 2003).
The distinct roles of trans-associated Tie2 and extracellular matrix-anchored Tie2
We and Dr. Alitalo's group have recently clarified how Tie2 responds to Ang1 and activates distinct downstream signaling in the presence or absence of cell-cell contacts. First, we both noticed that the localization of Tie2 engaged with Ang1 depends on the presence or absence of cell-cell contacts. Tie2 is recruited to the cell-cell borders in the presence of cell-cell contacts, whereas it is localized to cell -ECM contacts in the absence of cell-cell contacts. In the cell-cell contacts, Ang1 induces transassociation of Tie2, thereby locating Tie2 at the borders. Ang1 is capable of binding to ECM, resulting in anchoring of Tie2 to cell-ECM attachments.
We examined the activation of AKT and ERK, which are hallmarks of cell survival and proliferation/migration, respectively (Eliceiri et al., 1998; Manning and Cantley, 2007). AKT is preferentially activated by Ang1 in the presence of cell-cell contacts. Consistently, Alitalo's group clearly showed Ang1-induced eNOS activation that is a substrate of AKT. In clear contrast, ERK is activated in the absence of cell-cell contacts. We delineated the signaling by which ERK is preferentially activated. Ang1 tied Tie2 to ECM, thereby accelerating the attachment of the cells to ECM. In turn, the assembly of initial cell-ECM adhesions, focal complexes, is promoted. Focal adhesions implicate focal adhesion kinase (FAK) in the activation of ERK, as evidenced by the fact that depletion of FAK resulted in the decreased ERK activation by Ang1. Alitalo's group noticed that in migrating endothelial cells lacking the cell-cell adhesions, Dok-R is phosphorylated by Ang1 and colocalized with Tie2 at the cell-ECM in the rear of the motile cells, suggesting the involvement of Dok-R in endothelial cell migration upon Ang1 stimulation.
Ang1 may not induce sprouting or branching from the pre-existing vessels, because pre-existing vessels are stabilized by Ang1. However, once cell-cell adhesion is disrupted by VEGF, Ang1 accelerates angiogenesis cooperatively with VEGF (Asahara et al., 1998). This potential angiogenic activity of Ang1 is confirmed in rabbit ischemic hind limb model (Chae et al., 2000). It is of note that Ang1 counteracts VEGF in the presence of cell-cell adhesion to inhibit VEGF-induced inflammation and VEGF-induced permeability (Gamble et al., 2000; Kim et al., 2001a). (We discuss this point later in this manuscript.)
How does Ang1-Tie2 signal regulate vascular integrity?
Alitalo's group have demonstrated that Ang1 reduces vascular endothelial cell permeability in association with vascular endothelial protein tyrosine phosphatase (VE-PTP). VE-PTP enhances VE-cadherin-mediated cell-cell adhesion and reduces vascular permeability (Nawroth et al., 2002). The important role of VE-PTP for vascular development is confirmed by knockout mice of VE-PTP (Baumer et al., 2006). In addition, it has been reported that VE-PTP interacts with Tie2 (Fachinger et al., 1999). Therefore, the same authors investigated the involvement of VE-PTP in the reduction of permeability mediated by Ang1-Tie2 and showed enhanced colocalization of Tie2 with VE-PTP.
We identified a panel of genes upregulated by Ang1-Tie2 signal in the presence of cell-cell contacts using microarray analyses. Among them, we further focused on a transcription factor, Krüppel-like factor 2 (KLF2). KLF2 belongs to a zinc-finger family of transcription factor (Lomberk and Urrutia, 2005; Atkins and Jain, 2007) and exhibits vascular protective roles (SenBanerjee et al., 2004; Bhattacharya et al., 2005). Therefore, we hypothesized that Ang1-Tie2-dependent stabilization of vasculature is mediated by KLF2. First, we examined the involvement of MEF2 transcription factor in Ang1-induced KLF2 expression, because MEF2C is shown to regulate KLF2 expression in shear stress-induced KLF2 expression (Parmar et al., 2006). Second, we tested whether MEF2-dependent KLF2 expression was mediated by phospahtidylinositol-3 kinase/AKT. Finally, we investigated whether the inhibitory effect of Ang1 on VEGF-mediated inflammation was dependent on KLF2. Collectively, we delineate a role for the Tie2-PI3K/AKT-MEF2-KLF2 signaling activated by Ang1 in anti-inflammatory action (Sako et al., 2008). We summarize the molecular mechanism how Ang1 maintains vascular quiescence and Ang1 accelerates vascular angiogenesis in the presence or absence of cell-cell adhesions, respectively (Figure 2).
The unsolved important questions in Angiopoietin-Tie signaling
There are still unanswered questions to fully understand Ang-Tie signaling, although Tie2 and Ang1 have been extensively studied. Is Tie1 a real receptor of Ang1? If so, what is the difference between Tie1 and Tie2? We first need to clearly analyze when and where Tie1 and Tie2 are expressed in the vasculature of the whole body. Development of anti-Tie1-specific antibody and anti-Tie2-antibody that can be used for immunohistochemistry will help us to scrutinize the expression of these two important receptors (Brown et al., 2000). The simultaneous examination of Tie1 mRNA and Tie2 mRNA by in situ hybridization may also help to investigate the functional difference between two receptors for angiogenesis.
Does Ang2 really antagonize Ang1 for the activation of Tie2? Forced expression of Ang2 disrupts the embryonic angiogenesis (Maisonpierre et al., 1997). It is very important to clarify when Ang2 is released from vascular endothelial cells and which signal induces Ang2 release, as several signaling cascades that regulate the expression and release of Ang2 have been identified (Jang et al., 2008; Simon et al., 2008; Xue et al., 2008). What is the physiological role for Ang2? It has been suggested that Ang2 induces inflammation to remodel the vasculature (Audoy-Remus et al., 2008; Tressel et al., 2008). Tie2 family receptors were originally identified in hematopoietic cells (Batard et al., 1996; Hashiyama et al., 1996). It is necessary to underpin this Ang2-mediated inflammation to extend the involvement of Ang family molecules in angiogenesis. Especially, it would be interesting to examine whether Tie2 family receptors are expressed in M1 macrophages and if they are activated by Ang2 released from vascular endothelial cells (Gordon, 2003).
There are still uncharacterized angiopoietins, Ang3 and Ang4 (Valenzuela et al., 1999; Xu et al., 2004). Besides these, angiopoietin-like family (Angptl) molecules have been recently shown to be involved in angiogenesis (Hato et al., 2008). The receptors for Angptls are not yet isolated, to date. Thus, to thoroughly understand Ang- and Angptl-regulated angiogenesis, the ligand-receptor coupling should be molecularly defined. We here summarize what should be clarified in the future (Figure 3). Once we can fully characterize Angs and Tie family receptors, we can optimize the treatment for anti-angiogenesis or pro-angiogenesis.
Conclusion
We overviewed the Ang1-Tie2-regulated signals for angiostasis and angiogenesis. The diversity of downstream signaling activated by Tie2 depends on the presence or absence of cell-cell contacts. Alitalo's group and ourselves have now demonstrated where and how Ang1-Tie2 complexes are formed in the vascular endothelial cells to determine the intracellular signaling. Finally, we further refer to the points that are unsolved but require answering in order to extend our knowledge to clinical translation in the treatment of patients who are suffering from excessive angiogenesis in tumors, ischemia in coronary artery diseases (Carmeliet, 2003, 2005), and leaky vessels in lymphedema (Lohela et al., 2003; Karpanen and Makinen, 2006).
Abbreviations
- Angptl:
-
angiopoietin-like family
- FAK:
-
focal adhesion kinase
- ISV:
-
intersomitic vessel
- KLF2:
-
Krüppel-like factor 2
- VE-cadherin:
-
vascular endothelial cadherin
- VE-PTP:
-
vascular endothelial protein tyrosine phosphatase
- VSMC:
-
vascular smooth muscle cells
References
Adams RH, Alitalo K . Molecular regulation of angiogenesis and lymphangiogenesis . Nat Rev Mol Cell Biol 2007 ; 8 : 464 - 478
Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM . Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization . Circ Res 1998 ; 83 : 233 - 240
Atkins GB, Jain MK . Role of Kruppel-like transcription factors in endothelial biology . Circ Res 2007 ; 100 : 1686 - 1695
Audoy-Remus J, Richard JF, Soulet D, Zhou H, Kubes P, Vallieres L . Rod-Shaped monocytes patrol the brain vasculature and give rise to perivascular macrophages under the influence of proinflammatory cytokines and angiopoietin-2 . J Neurosci 2008 ; 28 : 10187 - 10199
Batard P, Sansilvestri P, Scheinecker C, Knapp W, Debili N, Vainchenker W, Buhring HJ, Monier MN, Kukk E, Partanen J, Matikainen MT, Alitalo R, Hatzfeld J, Alitalo K . The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells . Blood 1996 ; 87 : 2212 - 2220
Baumer S, Keller L, Holtmann A, Funke R, August B, Gamp A, Wolburg H, Wolburg-Buchholz K, Deutsch U, Vestweber D . Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development . Blood 2006 ; 107 : 4754 - 4762
Bhattacharya R, SenBanerjee S, Lin Z, Mir S, Hamik A, Wang P, Mukherjee P, Mukhopadhyay D, Jain MK . Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2 . J Biol Chem 2005 ; 280 : 28848 - 28851
Brindle NP, Saharinen P, Alitalo K . Signaling and functions of angiopoietin-1 in vascular protection . Circ Res 2006 ; 98 : 1014 - 1023
Brown LF, Dezube BJ, Tognazzi K, Dvorak HF, Yancopoulos GD . Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma . Am J Pathol 2000 ; 156 : 2179 - 2183
Carmeliet P . Angiogenesis in health and disease . Nat Med 2003 ; 9 : 653 - 660
Carmeliet P . Angiogenesis in life, disease and medicine . Nature 2005 ; 438 : 932 - 936
Cascone I, Audero E, Giraudo E, Napione L, Maniero F, Philips MR, Collard JG, Serini G, Bussolino F . Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1 . Blood 2003 ; 102 : 2482 - 2490
Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, Kim HG, Ko JK, Koh GY . Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization . Arterioscler Thromb Vasc Biol 2000 ; 20 : 2573 - 2578
Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML . Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo . Genes Dev 1994 ; 8 : 1897 - 1909
Duronio V . The life of a cell: apoptosis regulation by the PI3K/PKB pathway . Biochem J 2008 ; 415 : 333 - 344
Eliceiri BP, Klemke R, Stromblad S, Cheresh DA . Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis . J Cell Biol 1998 ; 140 : 1255 - 1263
Fachinger G, Deutsch U, Risau W . Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2 . Oncogene 1999 ; 18 : 5948 - 5953
Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, Kriz W, Thurston G, Augustin HG . The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies . Blood 2004 ; 103 : 4150 - 4156
Fiedler U, Augustin HG . Angiopoietins: a link between angiogenesis and inflammation . Trends Immunol 2006 ; 27 : 552 - 558
Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG . Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation . Nat Med 2006a ; 12 : 235 - 239
Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG . Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation . Nat Med 2006b ; 12 : 235 - 239
Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, Shibuya M, Takakura N, Koh GY, Mochizuki N . Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1 . Nat Cell Biol 2008 ; 10 : 513 - 526
Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD . Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1 . Dev Cell 2002 ; 3 : 411 - 423
Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas MA . Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions . Circ Res 2000 ; 87 : 603 - 607
Gordon S . Alternative activation of macrophages . Nat Rev Immunol 2003 ; 3 : 23 - 35
Harfouche R, Gratton JP, Yancopoulos GD, Noseda M, Karsan A, Hussain SN . Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases . FASEB J 2003 ; 17 : 1523 - 1525
Hashiyama M, Iwama A, Ohshiro K, Kurozumi K, Yasunaga K, Shimizu Y, Masuho Y, Matsuda I, Yamaguchi N, Suda T . Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells . Blood 1996 ; 87 : 93 - 101
Hato T, Tabata M, Oike Y . The role of angiopoietin-like proteins in angiogenesis and metabolism . Trends Cardiovasc Med 2008 ; 18 : 6 - 14
Jang C, Koh YJ, Lim NK, Kang HJ, Kim DH, Park SK, Lee GM, Jeon CJ, Koh GY . Angiopoietin-2 Exocytosis Is Stimulated by Sphingosine-1-Phosphate in Human Blood and Lymphatic Endothelial Cells . Arterioscler Thromb Vasc Biol 2008 ; : -
Jones N, Chen SH, Sturk C, Master Z, Tran J, Kerbel RS, Dumont DJ . A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function . Mol Cell Biol 2003 ; 23 : 2658 - 2668
Kanda S, Miyata Y, Mochizuki Y, Matsuyama T, Kanetake H . Angiopoietin 1 is mitogenic for cultured endothelial cells . Cancer Res 2005 ; 65 : 6820 - 6827
Karpanen T, Makinen T . Regulation of lymphangiogenesis--from cell fate determination to vessel remodeling . Exp Cell Res 2006 ; 312 : 575 - 583
Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY . Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway . Circ Res 2000 ; 86 : 24 - 29
Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY . Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells . J Biol Chem 2001a ; 276 : 7614 - 7620
Kim I, Moon SO, Park SK, Chae SW, Koh GY . Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression . Circ Res 2001b ; 89 : 477 - 479
Kim I, Ryu YS, Kwak HJ, Ahn SY, Oh JL, Yancopoulos GD, Gale NW, Koh GY . EphB ligand, ephrinB2, suppresses the . FASEB J 2002 ; 16 : 1126 - 1128
Koh GY, Kim I, Kwak HJ, Yun MJ, Leem JC . Biomedical significance of endothelial cell specific growth factor, angiopoietin . Exp Mol Med 2002 ; 34 : 1 - 11
Lee HJ, Cho CH, Hwang SJ, Choi HH, Kim KT, Ahn SY, Kim JH, Oh JL, Lee GM, Koh GY . Biological characterization of angiopoietin-3 and angiopoietin-4 . FASEB J 2004 ; 18 : 1200 - 1208
Lohela M, Saaristo A, Veikkola T, Alitalo K . Lymphangiogenic growth factors, receptors and therapies . Thromb Haemost 2003 ; 90 : 167 - 184
Lomberk G, Urrutia R . The family feud: turning off Sp1 by Sp1-like KLF proteins . Biochem J 2005 ; 392 : 1 - 11
Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD . Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis . Science 1997 ; 277 : 55 - 60
Manning BD, Cantley LC . AKT/PKB signaling: navigating downstream . Cell 2007 ; 129 : 1261 - 1274
Master Z, Jones N, Tran J, Jones J, Kerbel RS, Dumont DJ . Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak . EMBO J 2001 ; 20 : 5919 - 5928
Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D . VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts . EMBO J 2002 ; 21 : 4885 - 4895
Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, Altieri DC, Sessa WC . Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway . J Biol Chem 2000 ; 275 : 9102 - 9105
Parmar KM, Larman HB, Dai G, Zhang Y, Wang ET, Moorthy SN, Kratz JR, Lin Z, Jain MK, Gimbrone MA, Garcia-Cardena G . Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2 . J Clin Invest 2006 ; 116 : 49 - 58
Peters KG, Kontos CD, Lin PC, Wong AL, Rao P, Huang L, Dewhirst MW, Sankar S . Functional significance of Tie2 signaling in the adult vasculature . Recent Prog Horm Res 2004 ; 59 : 51 - 71
Saharinen P, Kerkela K, Ekman N, Marron M, Brindle N, Lee GM, Augustin H, Koh GY, Alitalo K . Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2 . J Cell Biol 2005 ; 169 : 239 - 243
Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, Olsen BR, Alitalo K . Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts . Nat Cell Biol 2008 ; 10 : 527 - 537
Sako K, Fukuhara S, Minami T, Hamakubo T, Song H, Kodama T, Fukamizu A, Gutkind JS, Koh GY, Mochizuki N . Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2 . J Biol Chem 2008 ; : -
Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y . Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation . Nature 1995 ; 376 : 70 - 74
Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG . The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism . J Cell Sci 2005 ; 118 : 771 - 780
SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, Feinberg MW, Chen Z, Simon DI, Luscinskas FW, Michel TM, Gimbrone MA, Garcia-Cardena G, Jain MK . KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation . J Exp Med 2004 ; 199 : 1305 - 1315
Simon MP, Tournaire R, Pouyssegur J . The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1 . J Cell Physiol 2008 ; 217 : 809 - 818
Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD . Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis . Cell 1996 ; 87 : 1171 - 1180
Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD . Angiopoietin-1 protects the adult vasculature against plasma leakage . Nat Med 2000 ; 6 : 460 - 463
Tressel SL, Kim H, Ni CW, Chang K, Velasquez-Castano JC, Taylor WR, Yoon YS, Jo H . Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis . Arterioscler Thromb Vasc Biol 2008 ; 28 : 1989 - 1995
Valenzuela DM, Griffiths JA, Rojas J, Aldrich TH, Jones PF, Zhou H, McClain J, Copeland NG, Gilbert DJ, Jenkins NA, Huang T, Papadopoulos N, Maisonpierre PC, Davis S, Yancopoulos GD . Angiopoietins 3 and 4: diverging gene counterparts in mice and humans . Proc Natl Acad Sci USA 1999 ; 96 : 1904 - 1909
Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM . Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2 . J Biol Chem 1998 ; 273 : 18514 - 18521
Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG . Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues . Circ Res 1997 ; 81 : 567 - 574
Xu Y, Liu YJ, Yu Q . Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis . Cancer Res 2004 ; 64 : 6119 - 6126
Xue Y, Cao R, Nilsson D, Chen S, Westergren R, Hedlund EM, Martijn C, Rondahl L, Krauli P, Walum E, Enerback S, Cao Y . FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue . Proc Natl Acad Sci USA 2008 ; 105 : 10167 - 10172
Acknowledgements
We thank Dr. Gou Young Koh for his comments, Dr. Kari Alitalo for helpful input, and Ms. Yuko Matsuura for her assistance. Our works were supported in part by grants from the Ministry of Education, Science, Sports and Culture of Japan; the Ministry of Health, Labour, and Welfare of Japan; and the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Fukuhara, S., Sako, K., Noda, K. et al. Tie2 is tied at the cell-cell contacts and to extracellular matrix by Angiopoietin-1. Exp Mol Med 41, 133–139 (2009). https://doi.org/10.3858/emm.2009.41.3.016
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3858/emm.2009.41.3.016
Keywords
This article is cited by
-
Integrin-specific hydrogels for growth factor-free vasculogenesis
npj Regenerative Medicine (2022)
-
In Vivo Targeting of the Neurovascular Unit: Challenges and Advancements
Cellular and Molecular Neurobiology (2022)
-
Human urine-derived stem cell-derived exosomal miR-21-5p promotes neurogenesis to attenuate Rett syndrome via the EPha4/TEK axis
Laboratory Investigation (2021)
-
Stem Cell Sources and Graft Material for Vascular Tissue Engineering
Stem Cell Reviews and Reports (2018)
-
Multimodal Genetic Approach for Molecular Imaging of Vasculature in a Mouse Model of Melanoma
Molecular Imaging and Biology (2017)